This page is part of the FHIR Specification (v4.3.0-snapshot1: Release 4B Snapshot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw XML (canonical form + also see XML Format Specification)
Example of clinicalusedefinition (id = "example")
<?xml version="1.0" encoding="UTF-8"?> <ClinicalUseDefinition xmlns="http://hl7.org/fhir"> <id value="example"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative</b> </p> <div> <p> Resource "example" </p> </div> <p> <b> type</b> : contraindication</p> <blockquote> <p> <b> contraindication</b> </p> </blockquote> </div> </text> <type value="contraindication"/> <contraindication> <diseaseSymptomProcedure> <concept> <coding> <system value="http://ema.europa.eu/example/contraindicationsasdisease-symptom-procedure"/> <code value="Coagulopathiesandbleedingdiatheses(exclthrombocytopenic)"/> </coding> <text value="Hepatic disease associated with coagulopathy and clinically relevant bleeding risk"/> </concept> </diseaseSymptomProcedure> <comorbidity> <concept> <coding> <system value="http://ema.europa.eu/example/comorbidity"/> <code value="Hepaticdisease"/> </coding> </concept> </comorbidity> </contraindication> </ClinicalUseDefinition>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.